REMEVi Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.1/10
Best for: bilingual, LegitScript-certified compounded GLP-1
REMEVi scores highest on state availability and ease of access.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated. It offers compounded semaglutide (from $199/mo on the 52-week plan) and tirzepatide (from $269/mo), provider-managed with weekly titration and overnight shipping from an NPI-verified pharmacy, at the same price every month with no hidden fees and cancel-anytime. REMEVi is LegitScript-certified and licensed in all 50 states plus DC. Compounded meds are not FDA-approved (disclosed); the pharmacy is NPI-verified but not named.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to REMEVi
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Brightmeds
Best for: compounded or brand GLP-1 bundled with TRT and peptides for men
Editorial score · methodology
REMEVi at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (52-week plan; month-to-month $279/mo. Same price every month (no titration hikes))
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored REMEVi
Each dimension is scored algorithmically from REMEVi’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.4/10At $199/mo, REMEVi runs about 18% above the $169 median for GLP-1 providers.
Effectiveness25%
8.7/10REMEVi offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.0/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
8.7/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-08-02).
Accessibility10%
8.9/10REMEVi treats patients in all 50 states.
Support10%
6.5/10REMEVi provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this REMEVi review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with REMEVi
We walked REMEVi’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a 5-minute online intake with no card required.
- 2A provider reviews your case within 24 hours via async or live consultation.
- 3If prescribed, medication ships on days 3-4 by overnight cold-chain delivery.
- 4A care coordinator conducts biweekly check-ins afterward.
- Monthly pricing is displayed upfront: semaglutide injection $149 first month then $279/mo, oral semaglutide $219/$349, tirzepatide $249/$379, with a $130 welcome discount auto-applied.
- Flat pricing at every dose is promised with monthly, 12-week, and 52-week commitment options; longer commitments carry discounts.
- Monthly plan states you can cancel anytime; a refund policy link is provided but full terms not shown.
- Free overnight cold-chain shipping to all 50 states plus DC, bundling visits, meds, coaching and shipping.
- Site mentions quarterly labs and an EKG for injection protocols.
REMEVi customer support
- Phone
- (702) 352-4746
GLP-1 medications REMEVi offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides REMEVi offers
Beyond GLP-1s, REMEVi also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
52-week plan; month-to-month $279/mo. Same price every month (no titration hikes)
52-week plan; month-to-month $339/mo
Ready to get started?
Plans and promotions change often — check REMEVi's current pricing and active discounts before you decide.
What we like
- The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
- Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
- LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
- Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)
Watch-outs
- Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
- Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
- The specific compounding pharmacy is not named (described as 'NPI-verified')
- A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements
Is REMEVi worth it? Our verdict
REMEVi positions itself around one thing: bilingual, LegitScript-certified compounded GLP-1. It runs $199/month — a premium to the category, so the extras need to justify it. It treats patients in all 50 states, so access isn't a barrier.
What gives REMEVi its own flavor: Bilingual (EN/ES), LegitScript Verified, and Price-locked.
How much REMEVi actually costs
- Compounded semaglutide — $199/month
- Compounded tirzepatide — $269/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so REMEVi's standing rate sits at the premium end.
For a direct comparison, RNK Health runs semaglutide and tirzepatide from $197/month — worth pricing against REMEVi before you commit.
Medications: what REMEVi prescribes
REMEVi prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who REMEVi is best for — and who should skip it
A good fit if you…
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
REMEVi treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
REMEVi costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Breeze Meds is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
REMEVi scores highest on state availability and ease of access.
Ready to start with REMEVi?
Starting at $199/month. See current pricing and start your free consultation.
REMEVi might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Oak.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this REMEVi review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See REMEVi's current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.